Targeting GCN2 or elevating tRNAGly levels may be useful in Charcot-Marie-Tooth disease Sep. 20, 2021
TRIM47 targeting shows potential for treating breast cancer refractory to endocrine therapy Sep. 20, 2021
Clarus licenses rights to McGill technology to treat conditions associated with CoQ10 deficiencies Sep. 17, 2021
Targeting RON short form suppresses breast cancer metastasis through subverted immunosuppression Sep. 17, 2021
Tarveda and SciClone enter license agreement for preclinical PI3K miniature drug conjugates Sep. 17, 2021
RSS